Physician profile
Skye Brownson
NPI 1427609791
$6,375.46
in general payments reported to CMS, 2019-2025
25 companies · $596 in 2025
The $596 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $195 · 2022: $1,210 · 2023: $1,495 · 2024: $2,880 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,206 · Travel and Lodging: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,205.50 |
| Travel and Lodging | $764.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,378.04 | 2022-2025 | Watchman Flx, Watchman, Watchman Access System |
| Merck Sharp & Dohme LLC | $606.20 | 2022-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $541.20 | 2022-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals Lp | $371.12 | 2022-2025 | Farxiga, Lokelma |
| Medtronic, INC. | $279.17 | 2022-2024 | Cobalt Dr Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.69 | 2022-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $232.89 | 2022-2024 | Xarelto |
| Edwards Lifesciences Corporation | $228.85 | 2021-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $201.83 | 2022-2025 | Lifevest |
| Philips North America LLC | $171.50 | 2023-2024 | (9520) Igt Devices Undivided, (Ck4) Mcot |
| Sanofi-Aventis U.S. LLC | $170.33 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $157.32 | 2022-2025 | |
| Amgen INC. | $134.68 | 2022-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $117.81 | 2025 | Assure Wcd |
| Atricure, INC. | $88.82 | 2022-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $81.98 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $67.53 | 2023-2024 | Inpefa |
| Biosense Webster, INC. | $59.70 | 2022 | |
| Esperion Therapeutics, INC. | $49.39 | 2024 | Nexletol |
| Scpharmaceuticals INC. | $48.30 | 2024-2025 | |
| Cardiva Medical, INC. | $47.47 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Novo Nordisk INC | $38.15 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Impulse Dynamics (USA) INC. | $22.95 | 2023 | Optimizer |
| Baxter Healthcare | $14.39 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $14.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Skye Brownson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.